Salih, Zinnor N.

HRN: 05-56-09  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/29/2023
CEFTRIAXONE 1G (VIAL)
09/29/2023
10/05/2023
IV
2g
OD
Infected Wound
Checking Final Appropriateness 
09/29/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
09/29/2023
10/05/2023
IV
600mg
Q8
Infected Wound
Checking Final Appropriateness 
10/03/2023
CLINDAMYCIN 300MG (CAP)
10/03/2023
10/10/2023
PO
300mg
QID
Infected Wound, Left Axilla
Checking Final Appropriateness 
10/03/2023
CEFIXIME 200MG (CAP)
10/03/2023
10/10/2023
PO
200mg
BID
Infected Wound, Left Axilla
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: